Doping control analysis of GW1516 in equine plasma using liquid chromatography/electrospray ionization Q‐Exactive high‐resolution mass spectrometry
- 10 August 2020
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 34 (23) , e8920
Abstract
Rationale: GW1516 is a peroxisome proliferator‐activated receptor‐δ agonist in the class of hormones and metabolic modulators. The use of GW1516 is banned in both horseracing and equestrian competitions. To the best of our knowledge, this is the first metabolic study of GW1516 in horses. Methods: After protein precipitation of pre‐ and post‐administration plasma GW1516 samples, the supernatants were analyzed using liquid chromatography/electrospray ionization Q‐Exactive high‐resolution mass spectrometry to detect GW1516 and its metabolites. Monoisotopic ions of GW1516 and its metabolites were monitored from the full‐scan mass spectral data of pre‐ and post‐administration samples. Quantification methods were developed and validated to establish the elimination profiles of GW1516, its sulfoxide, and its sulfone in equine plasma. Results: GW1516 and its four metabolites GW1516 sulfoxide, GW1516 sulfone, 5‐(hydroxymethyl)‐4‐methyl‐2‐(4‐trifluoromethylphenyl)thiazole (HMTT), and M1 were detected in post‐administration plasma samples. GW1516 sulfoxide, GW1516 sulfone, and HMTT were identified by comparison with their respective reference standards whereas M1 was tentatively identified as 4‐methyl‐2‐[4‐(trifluoromethyl)phenyl]‐1,3‐thiazole‐5‐carboxylic acid by mass spectral interpretation. GW1516 had the longest detection time in post‐administration plasma. The elimination profiles of GW1516, its sulfoxide, and its sulfone in plasma were established. Conclusions: For the purpose of doping control, GW1516 is recommended as the target analyte to be monitored in equine plasma due to its long detection time (around 1 week) and the ready availability of its reference material.Keywords
This publication has 10 references indexed in Scilit:
- Detection of prohibited substances in equine hair by ultra‐high performance liquid chromatography–triple quadrupole mass spectrometry – application to doping control samplesDrug Testing and Analysis, 2018
- Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometryBiomedical Chromatography, 2017
- Expanding the Versatility of a Quantitative Determination Range Adjustment Technique Using In-Source CID in LC/MS/MSCHROMATOGRAPHY, 2017
- A simultaneous determination method for 5‐fluorouracil and its metabolites in human plasma with linear range adjusted by in‐source collision‐induced dissociation using hydrophilic interaction liquid chromatography–electrospray ionization–tandem mass spectrometryBiomedical Chromatography, 2016
- Shifting the Linear Range in Electrospray Ionization by In-Source Collision-Induced DissociationChemical and Pharmaceutical Bulletin, 2016
- New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver diseaseExpert Opinion on Pharmacotherapy, 2014
- Effect of PPARβ/δ Agonist on the Placentation and Embryo‐Fetal Development in RatsBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2013
- Synthesis, Mass Spectrometric Characterization, and Analysis of the PPARδ Agonist GW1516 and Its Major Human Metabolites: Targets in Sports Drug Testing2012
- Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urineDrug Testing and Analysis, 2012
- Characterization of two major urinary metabolites of the PPARδ-agonist GW1516 and implementation of the drug in routine doping controlsAnalytical and Bioanalytical Chemistry, 2009